Individualized immunoglobulin treatment in pediatric patients with primary humoral immunodeficiency disease.

Journal Article (Journal Article;Review)

Primary immunodeficiency diseases (PIDD) are a group of genetic conditions that are generally considered to be under-diagnosed, and gaps may exist in the knowledge of treatment options. This review focuses on the diagnosis of pediatric patients with primary antibody deficiency and considerations for treatment with immunoglobulin (IgG) to optimize multiple dosing variables and minimize adverse events. The possibility of individualizing IgG therapy in clinical practice represents, in this field, the next pivotal step with the goal of improving the quality of life of pediatric patients with PIDD.

Full Text

Duke Authors

Cited Authors

  • Patel, NC

Published Date

  • September 2018

Published In

Volume / Issue

  • 29 / 6

Start / End Page

  • 583 - 588

PubMed ID

  • 29744952

Electronic International Standard Serial Number (EISSN)

  • 1399-3038

Digital Object Identifier (DOI)

  • 10.1111/pai.12923


  • eng

Conference Location

  • England